[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100575607":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":12,"locations":17,"responsibleParty":34,"collaborators":7,"id":36,"slug":37,"hasResults":38,"nctId":39,"briefTitle":40,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":38,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":7,"studyType":48,"phases":7,"briefSummary":49,"conditions":50,"keywords":7,"overallStatus":20,"whyStopped":7,"lastUpdateSubmitDate":52,"lastUpdatePostDateStruct":53,"startDateStruct":56,"completionDateStruct":58,"leadSponsor":60,"locationsCount":61},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Alessio Giuseppe Morganti, MD","PRINCIPAL_INVESTIGATOR",[13],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},"CONTACT","+39 0516363136","alessio.morganti2@unibo.it",[18],{"facility":19,"status":20,"city":21,"state":7,"zip":22,"country":23,"countryCode":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"IRCCS Azienda Ospedaliero - Universitaria di Bologna","RECRUITING","Bologna","40138","Italy","IT",{"type":26,"coordinates":27},"Point",[28,29],11.33875,44.49381,{"lat":29,"lon":28},[32,33],{"name":10,"role":14,"phone":15,"phoneExt":7,"email":16},{"name":10,"role":11,"phone":7,"phoneExt":7,"email":7},{"type":35,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100575607","evaluation-of-toxicity-and-outcomes-of-different-therapeutic-strategies-in-patients-with-uterine-neoplasms-100575607",false,"NCT06774482","Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms","Evaluation of Toxicity and Outcomes of Different Therapeutic Strategies in Patients With Uterine Neoplasms Treated With Radiotherapy at the Sant'Orsola Polyclinic in Bologna.","Inclusion Criteria:\n\n* Female patients, aged ≥ 18 years, with a new or previous diagnosis of malignant uterine neoplasm, starting from 01\u002F01\u002F2000, treated at the Radiotherapy Unit of the Sant'Orsola Polyclinic\n* Obtaining informed consent\n\nExclusion Criteria:\n\n* Patients with a new or previous diagnosis of malignant uterine neoplasm who choose not to undergo radiation treatment at the Radiotherapy Unit of the Sant'Orsola Polyclinic","FEMALE","18 Years",{"count":46,"type":47},3000,"ESTIMATED","OBSERVATIONAL","The single-center observational study aims to collect data related to the radiation treatment of uterine neoplasms. The purpose of the study is to systematically gather data on radiation treatment in uterine neoplasms in order to evaluate tumor response and potential toxicity in relation to dosages, fractionation, and techniques used, as well as the combination with other therapies and the characteristics of the disease.\n\nAdditionally, collecting data on both the characteristics of the disease and patients' comorbidities in a large sample may allow for the evaluation of any possible correlation with radiation-induced toxicities, with the aim of being able to predict and prevent them in a personalized manner in the future.\n\nTherefore, the study's goal is to evaluate tumor response and any potential toxicity after radiotherapy treatment in relation to treatment settings, dosages, and techniques used, both for new diagnoses and for cases already diagnosed and treated from 01\u002F01\u002F2000 onwards at the Radiotherapy Unit of Sant'Orsola-Malpighi Polyclinic.\n\nThe structured collection of data necessary for the evaluation of the objectives will cover the observation period from 01\u002F01\u002F2000 to 15\u002F12\u002F2030, for a total of approximately 5000 patients.",[51],"Uterine Neoplasms","2025-01-08",{"date":54,"type":55},"2025-01-14","ACTUAL",{"date":57,"type":55},"2021-05-19",{"date":59,"type":47},"2030-12-31",{"name":5,"class":6},1]